FDA Outbreak Investigation - FDA Investigating Multistate Outbreak of Salmonella Sandiego Infections Linked to Hy-Vee Spring Pasta Salad

FDA Investigating Multistate Outbreak of Salmonella Sandiego Infections Linked to Hy-Vee Spring Pasta Salad

July 18, 2018

The U.S. Food and Drug Administration, along with the Centers for Disease Control and Prevention (CDC) and state and local partners, is investigating a multi-state outbreak of Salmonella Sandiego illnesses linked to Spring Pasta Salad sold at Hy-Vee locations in Iowa, Illinois, Kansas, Minnesota, Missouri, Nebraska, South Dakota, and Wisconsin.

Fast Facts

• The FDA, CDC, along with state and local officials are investigating a multi-state outbreak of SalmonellaSandiego infections linked to Hy-Vee Spring Pasta Salad.
• The CDC reports that 21 people in 5 states (IA, MN, MO, NE, SD) have become ill. There have been 5 hospitalizations and no deaths.
• Following discussions with FDA, CDC, and state partners, Hy-Vee, Inc. voluntarily recalled their Spring Pasta Salad. The recalled products were distributed to all 244 Hy-Vee grocery store locations, which are located in Iowa, Illinois, Kansas, Minnesota, Missouri, Nebraska, South Dakota, and Wisconsin. The pasta salad was available in one- and three-pound, pre-packaged plastic containers, and was also available for purchase at the deli counter in custom quantities. If anyone has already purchased the Spring Pasta Salad and has it in their home, they should not consume it and should discard it. If consumers purchased pasta salad from a Hy-Vee deli counter and they are unsure of the type of pasta salad, they should not consume it and should discard it.
• Consumers who have symptoms of Salmonella infection should contact their health care provider to report their symptoms and receive care. Most people infected with Salmonella develop diarrhea, fever, and abdominal cramps. Most infections usually last 4 to 7 days and most people recover without treatment, however some people develop diarrhea so severe that they need to be hospitalized.
• As this is an ongoing investigation, the FDA will update this page as more information becomes available, such as product information, epidemiological results, and recalls.

Read the full update